Envision Healthcare Shares Down 2.96%; Earlier KeyBanc Cut Price Target On Co. 45% From $67 to $37, Citing Disappointing Q3 and 'Disastrous' Q4 Guidance, Still Sees Opportunity For Strategic Option Review To Create Value